These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15192151)

  • 1. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortagine: behavioral and autonomic function of the selective CRF receptor subtype 1 agonist.
    Farrokhi CB; Tovote P; Blanchard RJ; Blanchard DC; Litvin Y; Spiess J
    CNS Drug Rev; 2007; 13(4):423-43. PubMed ID: 18078427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice.
    Tovote P; Farrokhi CB; Gonzales RM; Schnitzbauer U; Blanchard DC; Blanchard RJ; Spiess J
    Psychoneuroendocrinology; 2010 Jul; 35(6):887-95. PubMed ID: 20036073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
    Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
    Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
    Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
    Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
    Jahn O; Tezval H; van Werven L; Eckart K; Spiess J
    Neuropharmacology; 2004 Aug; 47(2):233-42. PubMed ID: 15223302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.
    Lawrence AJ; Krstew EV; Dautzenberg FM; Rühmann A
    Br J Pharmacol; 2002 Jul; 136(6):896-904. PubMed ID: 12110614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
    Bonk I; Rühmann A
    Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
    Borelli KG; Brandão ML
    Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.